January 2026 in “Annals of Dermatology” Many dermatology patients experienced anxiety, depression, PTSD, and skin issues after the February 6, 2023 earthquakes, highlighting the need for combined skin and mental health care.
December 2025 in “ADMET & DMPK” Personalized treatments for hair loss focus on specific genetic and biological pathways.
December 2025 in “Frontiers in Nutrition” Collagen supplements may improve skin, joints, and recovery, especially with added nutrients.
A machine-learning test using hair can help detect autism early in infants.
Combining psychodermatology and PRP therapy can improve skin condition treatment by addressing both mental and physical health.
New peptides can delay aging and improve cell function.
August 2025 in “International Journal For Multidisciplinary Research” Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.
August 2025 in “Advances in Therapy” Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.
The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.
Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.
July 2025 in “Journal of Pharmacognosy and Phytochemistry” Plant-based therapies, like Aloe Vera and Cinnamon, may help manage PCOS symptoms with fewer side effects.
Many college students experience mild hair loss, influenced by factors like gender, family history, and lifestyle, suggesting a need for health education.
April 2025 in “PharmacoEconomics - Open” Patients with Alopecia Areata are willing to trade life duration for better quality of life.
Finasteride can cause long-term side effects like sexual dysfunction and depression.
Polarized microscopy helps identify hair irregularities in genetic disorders.
Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.
May 2024 in “Research Square (Research Square)” PCOS increases sexual pain distress in infertile women.
Women with PCOS have lower self-esteem and body image satisfaction.
Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.
January 2024 in “Medical Research Archives” An integrated approach involving dermatologists, psychiatrists, and psychologists is crucial for managing skin disorders linked to psychological factors.
October 2023 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism” Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.
September 2023 in “Journal of movement disorders” Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.
September 2023 in “medRxiv (Cold Spring Harbor Laboratory)” Long-COVID has diverse, long-term health impacts, especially in young people.
June 2023 in “International journal of biology, pharmacy and allied sciences” New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.
June 2023 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” Home photobiomodulation therapy can improve life quality and mobility for disabled individuals.
The study aims to create a model to improve personalized and preventive health care.
March 2023 in “Seminars in reproductive medicine” PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.
There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.
June 2022 in “Research Square (Research Square)” Lipid peroxidation may worsen social behavior issues in autism.
April 2022 in “Research Square (Research Square)” Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.